Vanguard Group’s Nephros NEPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
323,443
+119,285
| +58% | +$488K | ﹤0.01% | 3664 |
|
|
2025
Q1 | $351K | Buy |
204,158
+2,164
| +1% | +$3.72K | ﹤0.01% | 3965 |
|
|
2024
Q4 | $295K | Hold |
201,994
| – | – | ﹤0.01% | 4046 |
|
|
2024
Q3 | $345K | Buy |
201,994
+7,970
| +4% | +$13.6K | ﹤0.01% | 4053 |
|
|
2024
Q2 | $409K | Buy |
194,024
+18,375
| +10% | +$38.8K | ﹤0.01% | 4054 |
|
|
2024
Q1 | $385K | Buy |
175,649
+4,339
| +3% | +$9.5K | ﹤0.01% | 4073 |
|
|
2023
Q4 | $593K | Buy |
171,310
+598
| +0.4% | +$2.07K | ﹤0.01% | 3985 |
|
|
2023
Q3 | $253K | Buy |
170,712
+6,414
| +4% | +$9.49K | ﹤0.01% | 4208 |
|
|
2023
Q2 | $255K | Buy |
164,298
+17,613
| +12% | +$27.3K | ﹤0.01% | 4268 |
|
|
2023
Q1 | $157K | Hold |
146,685
| – | – | ﹤0.01% | 4353 |
|
|
2022
Q4 | $170K | Sell |
146,685
-1,098
| -0.7% | -$1.27K | ﹤0.01% | 4336 |
|
|
2022
Q3 | $134K | Buy |
147,783
+25,105
| +20% | +$22.8K | ﹤0.01% | 4467 |
|
|
2022
Q2 | $188K | Sell |
122,678
-300
| -0.2% | -$460 | ﹤0.01% | 4477 |
|
|
2022
Q1 | $541K | Hold |
122,978
| – | – | ﹤0.01% | 4386 |
|
|
2021
Q4 | $726K | Buy |
122,978
+21,360
| +21% | +$126K | ﹤0.01% | 4351 |
|
|
2021
Q3 | $891K | Buy |
101,618
+1,682
| +2% | +$14.7K | ﹤0.01% | 4274 |
|
|
2021
Q2 | $1.01M | Buy |
99,936
+3,741
| +4% | +$38K | ﹤0.01% | 4145 |
|
|
2021
Q1 | $640K | Buy |
96,195
+28,756
| +43% | +$191K | ﹤0.01% | 4092 |
|
|
2020
Q4 | $578K | Buy |
67,439
+10,702
| +19% | +$91.7K | ﹤0.01% | 3935 |
|
|
2020
Q3 | $410K | Hold |
56,737
| – | – | ﹤0.01% | 3847 |
|
|
2020
Q2 | $476K | Hold |
56,737
| – | – | ﹤0.01% | 3778 |
|
|
2020
Q1 | $357K | Buy |
+56,737
| New | +$357K | ﹤0.01% | 3742 |
|